Magnetic resonance spectroscopy in Parkinson's disease and parkinsonian syndromes
- PMID: 17637209
Magnetic resonance spectroscopy in Parkinson's disease and parkinsonian syndromes
Abstract
This paper looks at the use of magnetic resonance spectroscopy (MRS) for diagnostic and research purposes in Parkinson's disease and parkinsonian syndromes. The review considers both proton MRS (1H MRS) and phosphorus MRS (31 P MRS) studies. MRS is useful for diagnostic purposes, helping to differentiate Parkinson's disease from other parkinsonian syndromes. Even more usefully, MRS can be used for non invasive in vivo human research.
Similar articles
-
Metabolic changes detected by proton magnetic resonance spectroscopy in vivo and in vitro in a murin model of Parkinson's disease, the MPTP-intoxicated mouse.J Neurochem. 2008 May;105(3):874-82. doi: 10.1111/j.1471-4159.2007.05185.x. Epub 2007 Dec 13. J Neurochem. 2008. PMID: 18088356
-
[Clinical diagnostic criteria in Parkinson's disease and parkinsonian syndromes: review of the literature].Rev Neurol (Paris). 2000;156 Suppl 2 Pt 2:14-22. Rev Neurol (Paris). 2000. PMID: 10916032 Review. French.
-
[Diagnostic criteria for Parkinson syndromes, expecting Parkinson's disease].Rev Neurol (Paris). 2000;156 Suppl 2 Pt 2:43-50. Rev Neurol (Paris). 2000. PMID: 10916036 Review. French. No abstract available.
-
[Differential diagnosis of Parkinson's syndromes--an overview].Dtsch Med Wochenschr. 2009 Apr;134(17):892-6. doi: 10.1055/s-0029-1220245. Epub 2009 Apr 15. Dtsch Med Wochenschr. 2009. PMID: 19370503 Review. German.
-
Magnetic resonance imaging and spectroscopy in Parkinson's disease.Adv Neurol. 2001;86:197-203. Adv Neurol. 2001. PMID: 11553978 Review.
Cited by
-
Clinical and molecular characterisation of a Parkinson family with a novel PINK1 mutation.J Neurol. 2008 May;255(5):643-8. doi: 10.1007/s00415-008-0763-4. Epub 2008 Feb 21. J Neurol. 2008. PMID: 18286320
-
Parkinsonian syndromes.Neurol Sci. 2008 Oct;29 Suppl 3:308-10. doi: 10.1007/s10072-008-1004-4. Neurol Sci. 2008. PMID: 18941719 Review.
-
Mitochondrial dysfunction as a therapeutic target in progressive supranuclear palsy.J Mol Neurosci. 2011 Nov;45(3):684-9. doi: 10.1007/s12031-011-9606-3. Epub 2011 Jul 27. J Mol Neurosci. 2011. PMID: 21792607 Review.
-
In vivo neurometabolic profiling in orthostatic tremor.Medicine (Baltimore). 2016 Sep;95(37):e4848. doi: 10.1097/MD.0000000000004848. Medicine (Baltimore). 2016. PMID: 27631243 Free PMC article.
-
Moderate relationships between NAA and cognitive ability in healthy adults: implications for cognitive spectroscopy.Front Hum Neurosci. 2014 Feb 14;8:39. doi: 10.3389/fnhum.2014.00039. eCollection 2014. Front Hum Neurosci. 2014. PMID: 24592224 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Medical